Literature DB >> 12682064

Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney.

Kwon Moo Park1, Ji-Yeon Byun, Cornelis Kramers, Jee In Kim, Paul L Huang, Joseph V Bonventre.   

Abstract

Ischemic preconditioning renders the mouse kidney resistant to subsequent ischemia. Understanding the mechanisms responsible for ischemic preconditioning is important for formulating therapeutic strategies aimed at mimicking protective mechanisms. We report that the resistance afforded by 30 min of bilateral kidney ischemia persists for 12 weeks after preconditioning. The protection is reflected by improved postischemic renal function, reduced leukocyte infiltration, reduced postischemic disruption of the actin cytoskeleton, and reduced postischemic expression of kidney injury molecule-1 (Kim-1). The protection is observed in both BALB/c and C57BL/6J strains of mice. Thirty minutes of prior ischemia increases the expression of inducible nitric-oxide synthase (iNOS) and endothelial NOS (eNOS) and the expression of heat shock protein (HSP)-25 and is associated with increased interstitial expression of alpha-smooth muscle actin (alpha-SMA), an indication of long term postischemic sequelae. Treatment with Nomega-nitro-l-arginine (l-NNA), an inhibitor of NO synthesis, increases kidney susceptibility to ischemia. Gene deletion of iNOS increases kidney susceptibility to ischemia, whereas gene deletion of eNOS has no effect. Pharmacological inhibition of NOS by l-NNA or l-N6-(1-iminoethyl) lysine (l-NIL, a specific inhibitor of iNOS) mitigates the kidney protection afforded by 30 min of ischemic preconditioning. Fifteen minutes of prior ischemic preconditioning, which does not result in the disruption of the actin cytoskeleton, impairment of renal function, increased interstitial alpha-SMA, or increased iNOS or eNOS expression, but does increase HSP-25 expression, partially protects the kidney from ischemia on day 8 via a mechanism that is not abolished by l-NIL treatment. Thus, iNOS is responsible for a significant component of the long term protection afforded the kidney by ischemic preconditioning, which results in persistent renal interstitial disease, but does not explain the preconditioning seen with shorter periods of ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682064     DOI: 10.1074/jbc.M301778200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism.

Authors:  I Ruiz-Stewart; S R Tiyyagura; J E Lin; S Kazerounian; G M Pitari; S Schulz; E Martin; F Murad; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-18       Impact factor: 11.205

Review 2.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

3.  Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase.

Authors:  Xiao-Li Zhang; Zhen-Wen Yan; Wei-Wen Sheng; Jing Xiao; Zhen-Xing Zhang; Zhi-Bin Ye
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

4.  Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.

Authors:  Gene T Yocum; John G Gaudet; Susie S Lee; Yaakov Stern; Lauren A Teverbaugh; Robert R Sciacca; Charles W Emala; Donald O Quest; Paul C McCormick; James F McKinsey; Nicholas J Morrissey; Robert A Solomon; E Sander Connolly; Eric J Heyer
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 5.  Remote ischaemic conditioning-therapeutic opportunities in renal medicine.

Authors:  Lisa E Crowley; Christopher W McIntyre
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

Review 6.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

7.  Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells.

Authors:  Hak Joo Lee; Doug Yoon Lee; Meenalakshmi M Mariappan; Denis Feliers; Goutam Ghosh-Choudhury; Hanna E Abboud; Yves Gorin; Balakuntalam S Kasinath
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

8.  Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and brain injury.

Authors:  Guanxia Zhan; Polina Fenik; Domenico Pratico; Sigrid C Veasey
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

9.  Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Mitsuko Iguchi; Yoshihiko Kakinuma; Atsushi Kurabayashi; Takayuki Sato; Taro Shuin; Seung-Beom Hong; Laura S Schmidt; Mutsuo Furihata
Journal:  Nephron Exp Nephrol       Date:  2008-10-27

10.  KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation.

Authors:  Craig R Brooks; Melissa Y Yeung; Yang S Brooks; Hui Chen; Takaharu Ichimura; Joel M Henderson; Joseph V Bonventre
Journal:  EMBO J       Date:  2015-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.